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Background: Patients with heart failure (HF) must manage both a demanding treatment regimen and self-
care, which may lead to a burden of treatment. The purpose of this study was to assess the levels of burdens
from treatment and self-care and its associations with psychological distress and health-related quality of life.
Methods: In this cross-sectional study we collected self-report data from 125 patients diagnosed with HF,
New York Heart Association classification II and III, who received care in a nurse-led HF outpatient clinic.
Clinical variables were collected from the medical records. Data analyses comprised descriptive statistics and
partial correlations.
Results: The participants mean age was 67 (§9.2), most were male (74,4%) and the majority had reduced ejec-
tion fraction (EF 35.4 § 10.8). The highest mean burden scores emerged for insufficient medical information
(34.65, range 086), difficulty with health care service (34.57, range 081), and physical and mental fatigue
(34.12, range 090). Significant positive associations were observed between physical and mental fatigue
from self-care, role and social activity limitation, and psychological distress, and health-related QoL.
Conclusion: Burden of treatment is an important aspect of HF treatment as it contributes to valuable knowl-
edge on patient workload. This study emphasizes the need to simplify and tailor the treatment regimens to
alleviate the burden.
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Heart failure (HF) is a chronic progressive syndrome with multiple
aetiologies, affecting approximately 2% of the western adult popula-
tion in general, increasing to 5-9% in age > 65 years.1 The syndrome
is characterised by the heart’s inability to meet the body’s metabolic
demands, associated with activation of numerous neurohormonal
compensation-mechanisms.2 Advances in terms of treatment, pre-
vention, and rehabilitation have improved the prognosis for HF and
the patients’ quality of life.3 Yet, HF requires the patient to adhere to
a challenging medical treatment regimen and lifestyle changes, inaddition to managing symptoms and coordinating care.4 The treat-
ment and self-care tasks may contribute to a burden of treatment
(BoT), defined as the “workload” assigned to long term ill patients by
health care professionals and its impact on the patients’ well-being
and functioning.57 BoT refers to the imbalance between treatment-
related workload placed on patients by the health care system and
the patients’ capacity to engage in additional self-care.5,8 Qualitative
research on BoT among patients with chronic illness, including car-
diovascular disease, reveals that BoT is a multi-dimensional concept
that may change over time, according to illness severity and control,
and may increase with the number of treatment tools and the occur-
rence of co-morbidity.9 Consequently, increased BoT may result in
less understanding of the disease and its treatments, non-adherence
to treatment regimens (e.g., medications and dietary recommenda-
tions), disease deterioration, and thus, reduced health-related quality
of life (HRQoL).8 In HF, BoT seems to reduce the patients’ capacity to
follow treatment plans 10 and induces poor adherence.7,11,12 Taken
together, studies suggest that BoT may contribute to worsening of
the disease and more frequent episodes of decompensation.13,14
Despite the growing interest in BoT, few instruments to measure the
370 O.K. Nordfonn et al. / Heart & Lung 50 (2021) 369374concept exists, and few studies have measured the level of BoT
among people with HF.7,8,15 Therefore, one purpose of this study is to
assess the BoT in patients with HF.
Psychological distress (e.g., symptoms of depression and anxiety)
is common among patients with HF. Symptoms of anxiety and
depression were higher among patients with HF than controls of
healthy older individuals and other cardiovascular conditions.16,17
Moreover, psychological distress is associated with and might be a
determinant of HF self-care behavior and poorer HF outcomes.1820
The link between BoT (e.g., experienced self-care workload) and psy-
chological distress is less examined. Some studies indicate a correla-
tion between greater BoT and distress.15,21 However, no studies have
evaluated these associations in HF populations. Additionally,
increased levels of psychological distress in HF are associated with
lower levels of health-related quality of life (HRQoL) and poor treat-
ment adherence.18,22 Yet, few studies have addressed the contribu-
tions of BoT to HRQoL in patients with HF. Therefore, the second
purpose of this study is to evaluate the associations of dimensions of
BoT, with psychological distress and HRQoL in patients with HF.
Methods
Study design
The study used a cross-sectional design and a postal survey was
conducted. The recipients were patients with HF who received care
in a nurse-led HF outpatient clinic in a Norwegian university hospital.
This clinic provides time-limited follow-up care for patients with HF
in need of titration to optimize HF medication and includes health-
care education, lifestyle modification, and symptom assessments.
These services are provided by a specialist HF nurse in collaboration
with a cardiologist.
The study was approved by the Norwegian Regional Medical
Ethics Committee (REK no. 2017/75) and conducted in accordance
with the ethical guidelines of the World Medical Association’s Decla-
ration of Helsinki.23 All participants signed a written informed con-
sent. Information about the study, the possibility of withdrawing at
any time, and confidentiality were included in a letter accompanying
the questionnaire. Inclusion criteria were the following: (1) diagnosis
of HF confirmed by echocardiography at least 3 months prior to inclu-
sion, (2) New York Heart Association (NYHA) functional class II or III,
(3) ability to read and communicate in Norwegian and (4) aged 18-
80 years at the time of the study. Exclusion criteria were: (1) heart
transplant, (2) participation in other studies, and (3) impaired cogni-
tive condition determined by screening the ICD-diagnosis codes or
acute illness.
Data collection
Eligible participants were recruited by a research nurse between
September 2017 and April 2019 by the screening of the patient list at
the HF outpatient clinic. Data were collected through a questionnaire
on BoT, psychological distress and HRQoL posted to patients with all
types of HF (e.g., HF reduced ejection fraction (HFrEF), HF middle
range EF (HFmrEF), and HF preserved EF (HFpEF) and from medical
records. A reminder was sent to recipients who failed to return the
questionnaire by the stated deadline.
Measurements
Demographic and clinical variables
Demographic characteristics were collected by self-report in the
questionnaire and included sex, age, educational level, marital and
employment status. Clinical variables were collected by the research-
ers at the time of enrollment, and included comorbidity, time since
diagnosis, number of medications (e.g., all medications taken daily),and NYHA functional class, and were obtained from the respondents’
medical records.
Burden of treatment
To measure BoT, the Patient Experience with Treatment and Self-
management (PETS) instrument was used.15 It consists of 9 dimen-
sions and 48 items assessing the burden from chronic illness treat-
ment and self-care experienced the last four weeks in the
dimensions: medical information (7 items), medications (7 items),
medical appointments (6 items), monitoring health (2 items), relation-
ships with others (4 items), health care expenses (4 items), difficulty
with health care services (7 items), role and social activity limitations
due to self-care (6 items), and physical and mental fatigue due to self-
care (5 items). The participants provide responses on either a 4-point
or a 5-point categorical ordered scale, depending on content domain
(e.g. very easy to very difficult, not at all to very much, strongly agree
to strongly disagree, and never to always). For some of the items, a
‘not applicable’ option is available. PETS domains have a score range
of 0100, with a higher score suggesting greater perceived BoT. Each
dimension is scored separately. PETS has been validated in a popula-
tion of mixed chronic conditions,15 and people with diabetes.21 This
study used the Norwegian version of PETS.24 The internal consistency
was good 25 in the present study (Cronbach’s alpha, ranging from
0.72 to 0.91 across dimensions).
Psychological distress
Psychological distress was assessed with the validated Hopkins
Symptom Checlist (HSCL-10).26 It comprises 10 questions regarding
symptoms of depression and anxiety experienced the previous
week.27 The participants provide responses on a 4-point Likert scale
ranging from “not troubled” (1) to “heavily troubled” (4), yielding a
total score ranging from 1 to 4. Higher total score indicate higher
level of psychological distress. The average item score is used as a
measure of psychological distress with a cut-off set at 1.85, frequently
used in adults.26 The internal consistency was high in the present
study (Cronbach’s alpha = 0.91).25
Health-related quality of life
HRQoL was measured by the validated Minnesota Living with
Heart Failure Questionnaire (MLHFQ).28 It is a disease-specific 21-
item scale measuring the subjective perception of the effect of HF
and its treatment on patients’ daily lives as experienced the last
month. Each item response is scored from 0 (“no impact”) to 5
(“extremely negative impact”) yielding an overall total score range
between 0 and 105. Higher scores indicate poorer HRQoL and higher
adverse effects of HF on patients’ lives. The instrument has been
widely used to measure HRQoL among HF patients.2931 The internal
consistency was high in the present study (Cronbach’s
alpha = 0.92).25
Data analysis
Data were examined for their distributional properties, outliers,
and missing data. Descriptive statistics were used to summarise the
demographic and clinical characteristics of the sample, and levels of
BoT, psychological distress, and HRQoL. Pearson correlation coeffi-
cients were calculated to determine the correlations among BoT, psy-
chological distress, and HRQoL. Partial correlation analyses were
performed to determine the statistical associations between BoT, psy-
chological distress and HRQoL when adjusting for age, sex, and dicho-
tomised NYHA classes II and III. The data were analysed using the
Statistical Package for Social Science (SPSS) version 25 (SPSS Inc,
Armonk NY, USA). The significance level was set at p< 0.05 for all sta-
tistical tests. The sample size was calculated based on the rule-of-
thumb by Green,32 with the following calculations: minimum
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the minimum number of cases would be 122 (50 + 8 £ 9).Results
Study population
The demographic and clinical characteistics of the study sample
are summarised in Table 1. Of the 199 eligible participants, 125
returned the questionnaire, a response rate of 63%. The average age
(SD) of the participants was 67 (§ 9.2) years, (range 4280), 74.4%
were men, and 69.6% lived with a partner. The majority of the partici-
pants had HF with reduced EF. The mean EF was 35.4 (§10.8, range
1570), the average time since diagnosis of HF was 3.7 years; and
66.4% had NYHA class II. Most participants (69,6%) had comorbid con-
ditions and the most frequent was arrhythmia (27,8%), diabetes type
2 (26,2%) and kidney failure (23,8%). Participants took an average of
8 § 3.1 medications daily.Table 1
Demographic and clinical characteristics (n = 125).
Participants (n = 125)





Living conditions, n (%)
Living alone 35 (28)
Living with partner 87 (69.6)
Living with others 3 (2.4)
Education, n (%)
Primary school 49 (39.2)
High school 36 (28.8)
College/University 38 (30.4)
Missing 2 (1.6)
Currently employed, n (%)
Yes 17 (13.6)
Yes, part time 8 (6.4)
No 97 (77.6)
Missing 3 (2.4)
Time since diagnosis, mean years (§SD) 3.75 (5.5)
EF, mean (§SD) range 35.4 (10.8) 1570
Missing, n (%) 26 (20.8)




NYHA classification, n (%)
NYHA II 83 (66.4)




Comorbid conditions, n (%)
Arrhythmia 35 (27.8)
Asthma 6 (4.8)
Autoimmune disease 12 (9.5)
Cancer 12 (9.5)
COPD 20 (15.9)
Diabetes type 2 33 (26.2)
Kidney failure 30 (23.8)
Neurological disease 7 (5.6)
Medication, mean (§SD) range 8 (3.1) 319
Notes: Primary school, nine years in Norway
Abbreviations: SD, standard deviation; EF, ejection fraction;
HFrEF, heart failure reduced EF; HFmrEF, heart failure middle
range EF; HFpEF, heart failure preserved EF; NYHA, New York
Heart Association Classification; COPD, chronic obstructive pul-
monary disease.
* the percentage is calculated on the basis of 99 cases with
documented EF.BoT, psychological distress and HRQoL in heart failure
Table 2 shows the descriptive information and internal consis-
tency for BoT (PETS), psychological distress (HSCL-10), and HRQoL
(MLHFQ). Of the nine BoT dimensions, the highest mean (SD) scores
were obtained for the dimension medical information (34.65 § 18.2),
difficulty with health care services (34.57 § 19.0), and physical and
mental fatigue (34.12 § 21.0). Monitoring health also had a relatively
high mean score (30.86 § 21.1). These results indicate that patients
experience BoT because of their workload (e.g., medical information,
monitoring health), external stressors (e.g., difficulty with health care
service) and that the treatment and self-care affect their physical and
mental well-being (e.g., physical and mental fatigue). Relatively low
BoT scores were found for medications (16.16 § 17.3), medical
appointments (16.87 § 16.85), and relationships with others
(14.23 § 18.34). The mean level of psychological distress was 1.65
(§.58), and 25.6% of the participants scored 1.85, a valid cut-off
point for symptoms of depression and anxiety.26 The mean HRQoL
scores were 38.30 (§21.6).
Missing data ranged from 0% to 5.6% in all scales, except in PETS
dimensions monitoring health (9.6%), medical expenses (10.4%), and
difficulties with health care services (23.2%). Several PETS dimensions
have the response alternative “not applicable” which is treated as
missing together with un-answered items. When scoring PETS, miss-
ing data within each dimension are replaced with the mean of
remaining items as long as more than 50% are completed.15 In HSCL-
10 and MLHFQ, missing was handled by mean imputation if 80% of
the items were answered. Follow-up analysis of cases with no miss-
ing data was conducted. The pattern of results remained the same.
Included variables were tested for skewness and kurtosis. All data
were in a referenced normal area of skewness and kurtosis except for
the PETS dimension relationships with others (skewness 1.7 and kur-
tosis 3.0). We performed a log transformation, and a normalised score
of the dimension relationships with others was calculated (skewness
0.54; kurtosis 1.5) to assess correlations for the transformed score to
psychological distress and HRQoL. This procedure produced the same
results on correlations (psychological distress; r = 0.68**, HRQoL;
r = 0.56**). Results for correlations were interpreted in accordance
with Cohen’s suggestions,33 which define 0.50 as a strong correlation,
0.30 as medium, and 0.10 as weak.
Associations between BoT, psychological distress and HRQoL
As shown in Table 3, partial correlations (rp), controlling for age,
gender, and dichotomised NYHA class II and III, were statistically sig-
nificant for the relatinships between all BoT dimensions (p < 0.05)
except for difficulty with healthcare services, and HRQoL. Most correla-
tions were in the medium-to-large range of magnitude (e.g.,
rp  0.30). The BoT dimensions showing the strongest associations
with psychological distress were physical and mental fatigue
(rp = 0.75), relationships with others (rp = 0.65), and the role and social
activity limitations (rp = 0.62). For HRQoL, the strongest associations
were found for the BoT dimensions physical and mental fatigue
(rp = 0.53) and role and social activity limitation (rp = 0.51). All correla-
tions were positive, indicating that greater burden worsens the psy-
chological distress and HRQoL. The BoT dimensions medical
information and medications showed weaker associations to psycho-
logical distress and HRQoL
Discussion
In this study, BoT dimensions assessing patient workload (e.g.,
medical information, monitoring health), stressors (e.g., difficulty
with health care service), and the impact of treatment and self-care
causing physical and mental fatigue had the highest scores and
reflected greater burden. Burden from limitations of social lives and
Table 2
Descriptive statistics and reliability of nine BoT dimensions (PETS), psychological distress (HSCL-10) and HRQoL (MLHFQ).
Mean (95% CI) SD Median (IQR) Range Cronbach’s a
PETS dimensions (no of items)a
Medical information (7) 34.65 (31.38, 37.92) 18.24 32.14 (22) 086 0.88
Medication (7) 16.16 (13.05, 19.28) 17.36 12.50 (25) 075 0.91
Medical appointments (6) 16.87 (13.88, 19.85) 16.85 16.67 (29) 063 0.90
Monitoring health (2) 30.86 (26.92, 34.80) 21.13 25.00 (38) 088 0.77
Relationships with others (4) 14.23 (10.89, 17.57) 18.34 6.25 (25) 088 0.82
Medical expenses (4) 23.94 (20.09, 27.79) 20.54 25.00 (38) 081 0.91
Difficulty with health care services (7) 34.57 (30.72, 38.42) 19.01 33.33 (20) 081 0.81
Role and social activity limitations (6) 27.53 (23.04, 32.03) 24.87 22.92 (36) 0100 0.91
Physical and mental fatigue (5) 34.12 (30.30, 37.93) 21.00 35.00 (30) 090 0.89
HSCL-10b 1.65 (1.55, 1.76) .589 1.5 (0.69) 1.003.80 0.91
MLHFQc 38.30 (34.41, 42.19) 21.60 38.00 (35) 094 0.92
Abbreviations: SD, standard deviation; CI, confidence interval; IQR, inter quartile range; PETS, Patient Experience with Treat-
ment and Self-Management; HSCL, Hopkins Symptom Checklist; MLHFQ, Minnesota Living with Heart Failure Questionnaire.
a All PETS domain scores are standardised to a 0 (lower burden) to 100 (highest burden) scale.
b HSCL-10 has a total score ranging from 1 4.
c MLHFQ has an overall total score ranging between 0-105.
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self-care was also associated with higher psychological distress and
decreased HRQoL. Our results are consistent with observations of
other patient populations with chronic conditions. For example, Eton
et al.15 and Rogers et al.21 indicated a correlation between greater
BoT and overall physical and mental health in patients with multi-
morbidity and diabetes. Our study advances knowledge of this field
as it suggests that BoT dimensions assessing patient “work” have less
influence on emotional stress and HRQoL, and imply that the BoT
dimensions assessing the “impact” from treatment and self-care have
the greatest influence on well-being in patients with HF.
Our results suggests that access to and understanding of medical
information (e.g., learning about and understand your health prob-
lem and related medications, understand advice from health care
providers) create a substantial workload for patients with HF. Confu-
sion about medical information potentially may interfere with
patients’ self-care efforts.34,3 According to Kristiansen et al.,35
patients’ learning needs are connected to and triggered by their
everyday life and context, highlighting the need for health care pro-
fessionals to be aware of the patients’ every day as a starting point ofTable 3
Associations among BoT (PETS), psychological distress (HSCL-10) and HRQoL
(MLHFQ).




Medical information 0.24** 0.27** 122
Medications 0.29** 0.21* 122
Medical appointments 0.39** 0.31** 125
Monitoring health 0.32** 0.31** 113







Role and social activity
limitations
0.62** 0.51** 120
Physical and mental fatigue 0.75** 0.53** 119
Notes: 1.10-.29=weak correlations; .30-.49=medium correlations; .50-=strong
correlations. (According to Cohen’s correlation effect size, Cohen, 1988). 2 Partial
correlation; controlling for gender, age and NYHA class.
Abbreviations: PETS, Patient Experience with Treatment and Self-Management;
HSCL, Hopkins Symptom Checklist; MLHFQ, Minnesota Living with Heart Failure
Questionnaire.
* p < 0.05
** p < 0.01learning needs. Finding more efficient educational strategies is of
importance in HF as access to sources of understandable medical
information could contribute to a sense of control over one’s treat-
ment regimen and lessen the BoT.21
In the forms of BoT domains, our findings suggest that patients
with HF may experience BoT from difficulties with health care serv-
ices, seeing multiple health care providers who often communicate
ineffectively, and experience problems with filling out forms and get-
ting medical appointments in time. Especially, dealing with different
health care providers is observed as a challenge to the continuity of
care 36,37 and may result in a higher risk of readmission 34 and lack of
medication adherence.38 HF suggests a substantial need for
support.39,40 Frequent patient-centered visits to a nurse-led HF out-
patient clinic may be valuable to patients 41 and may assist patients
with HF to improve their self-care and thus decrease their risk of
readmission.42,43 However, excessive hospital and primary care
appointments may also increase the BoT, and there is a risk of bur-
dening patients through complex treatment regimens with multiple
health care providers. A careful appraisal of the individual patients’
health care interaction may contribute to evaluating BoT. Clinical
practice should focus on how to simplify and tailor the treatment reg-
imens to fit into the daily lives of patients with HF, perhaps by so-
called one-stop HF services.7 Interventions studying the effects of dif-
ferent models of care on BoT in HF is warranted.
Our findings also suggest that the treatment and self-care burden
patients physically and mentally, making them feel angry, preoccu-
pied, depressed, worn out and frustrated. These findings are
aligned with previous research reporting that HF self-care is burden-
some 4,18,44,45 and BoT is emotionally challenging.7,12 For patients
with HF, adherence to treatment and self-care is important for opti-
mal functioning and well-being.3 Still, HF treatment and self-care
work may add additional stress to patients, as they require energy
that patients with HF may lack. More research on how BoT affects
patients’ physical and mental well-being is needed. Furthermore,
more knowledge on how an individualized and tailored care may
ameliorate BoT is of importance.46
The current study revealed significant associations between BoT,
psychological distress and HRQoL, and most strongly with the bur-
dens leading to physical and mental fatigue, and limiting social activ-
ity and relationships. Unlike previous research on HF, this study
revealed that BoT might play a significant role in impaired HRQoL
and psychological distress. However, as BoT is not a part of the out-
come assessments of patients with HF in clinical practice, health care
professionals may underestimate the patients’ BoT and overlook the
O.K. Nordfonn et al. / Heart & Lung 50 (2021) 369374 373effects of the BoT on the patients’ daily lives.47 Our study suggests
that future clinical practice should emphasise HF patients’ experience
of BoT as an important aspect in treatment plans. Future studies
assessing BoT can offer insights that would enable the health care
system to take practical steps to improve HF care.
Methodological considerations
This study had some limitations. First, the findings should be
interpreted with caution due to the cross-sectional design. It is not
possible to establish the cause, or the directionality of the associa-
tions observed. Second, our results in terms of the burden of medical
expenses may be influenced by the fact that the study was conducted
in a country whose national health insurance coverage provides
health care services almost free of charge. Studies performed in other
cultural settings and with different forms of national health insurance
coverage found that burden from medical expenses as measured by
the PETS was associated with financial difficulty,15 and a less accessi-
ble health care service.21 Third, patients included in this study were
diagnosed with NYHA II and III, indicating mild to moderate physical
limitations in symptoms. Inclusion of only patients with NYHA class
III might have generated other results. In addition, no patients in
NYHA I or NYHA IV were included. Patients classified with NYHA I
experience no symptoms and no limitation in physical activity, and
patients in class IV are severely ill, experiencing symptoms even at
rest and often are bed-bound, normally assigned for transplant or
palliative care.48 Hence, both groups have risks of BoT and future
research in all NYHA classes can contribute important insights on lev-
els of burden. Fourth, data were collected from one outpatient clinic
with a limited sample with a majority of male participants which
could create a gender bias.49 Fifth, due to missing data in the dimen-
sion difficulty with health care services (23,2%) there is a risk of poten-
tial bias and reduced representativeness of the sample. According to
Eton et al.,50 missing data are expected in PETS due to the response
alternative “not applicable” being treated as missing based under the
assumption that “burden” cannot be assessed unless the question is
personally relevant. Finally, finding on the association between PETS
dimension physical and mental fatigue and psychological distress
should be interpreted with care, due to the likelihood that they mea-
sure the same construct, thereby explaining the strong correlation.Implications for future research
Future studies investigating BoT and its related factors in HF
should be conducted using a larger and equal sample of sexes, at vari-
ous locations to provide a comprehensive representation of patients
with HF’s BoT experiences and aim for a longitudinal design to cap-
ture changes in BoT over time. We also suggest future prospective
studies to explore if and how BoT changes during the HF trajectory.
Knowing that patients’ demographic characteristics, such as educa-
tion, have an impact on their chronic health conditions, future
research should focus on relations between sociodemographic factors
and BoT in patients with HF. More research should focus on HF and its
relations to different health care modes to mitigate BoT.Conclusion
BoT is an important aspect in the clinical care of patients with HF.
Insufficient medical information, difficulties with health care service,
and physical and mental fatigue due to self-care yielded the highest
burden scores. Significant associations suggest that BoT is linked to
psychological well-being and HRQoL in this patient group. A careful
evaluation of the individual patients’ treatment workload seems to
be vital in HF care.Author contributions
All authors have made substantial contributions to all parts of this
study. OKN, AMLH, IMM and LEB designed the study, handled and
analysed the data, prepared, drafted and revised the manuscript. AIL
contributed to interpretation of data, preparation, drafting and revi-
sion of manuscript.
Declaration of Competing Interest
The authors declare that there is no conflict of interest.
Acknowledgments
The authors would like to thank all the patients who gave of their
time and contributed to this study. Thanks to Biostatistician Ingvild
Dalen PhD, for statistical guidance and help. This research did not
receive any specific grant from funding agencies in the public, com-
mercial, or not-for-profit sectors.
References
1 Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Cham-
berlain AM, Chang AR, Cheng S, Delling FN, Djousse L. Heart disease and stroke sta-
tistics—2020 update: a report from the American Heart Association. Circulation.
2020;3:E139–E596.
2 Polikandrioti M, Goudevenos J, Michalis LK, Koutelekos J, Kyristi H, Tzialas D, et al.
Factors associated with depression and anxiety of hospitalised patients with heart
failure. Hellenic J Cardiol. 2015;56(1):26–35.
3 Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC
Guidelines for the diagnosis and treatment of acute and chronic heart failure: The
Task Force for the diagnosis and treatment of acute and chronic heart failure of the
European Society of Cardiology (ESC). Developed With the Special Contribution of the
Heart Failure Association (HFA) of the ESC. 18, 2016891–975.
4 Harkness K, Spaling MA, Currie K, Strachan PH, Clark AM. A systematic review of
patient heart failure self-care strategies. J Cardiovasc Nurs. 2015;30(2):121–135.
5 Eton DT, Ramalho de Oliveira D, Egginton JS, Ridgeway JL, Odell L, May CR, et al.
Building a measurement framework of burden of treatment in complex patients
with chronic conditions: a qualitative study. Patient Relat Outcome Meas.
2012;3:39–49.
6 May CR, Montori VM, Mair FS. We need minimally disruptive medicine. BMJ.
2009:339.
7 Gallacher K, May CR, Montori VM, Mair FS. Understanding patients’ experiences of
treatment burden in chronic heart failure using normalisation process theory. Ann
Fam Med. 2011;9(3):235–243.
8 May CR, Eton DT, Boehmer K, Gallacher K, Hunt K, MacDonald S, et al. Rethinking
the patient: using Burden of Treatment Theory to understand the changing dynam-
ics of illness. BMC Health Serv Res. 2014;14(1):281.
9 Sav A, King MA, Whitty JA, Kendall E, McMillan SS, Kelly F, et al. Burden of treat-
ment for chronic illness: a concept analysis and review of the literature. 2015. p.
312-24.
10 Gallacher K, Jani B, Morrison D, et al. Qualitative systematic reviews of treatment
burden in stroke, heart failure and diabetes-methodological challenges and solu-
tions. BMC Med Res Methodol. 2013 Dec 1;13(1):10.
11 Mair F, Browne S, Morrison D, Gallacher K, Macleod U, May CR. Treatment burden
in end stage heart failure (ESHF): a qualitative study. BMJ Support Palliative Care.
2011;1(Suppl 1):A8.. -A.
12 Nordfonn OK, Morken IM, Bru LE, Husebø AML. Patients’ experience with heart fail-
ure treatment and self-care—a qualitative study exploring the burden of treatment.
J Clin Nurs. 2019;28(910):1782–1793.
13 Riegel B, Lee CS, Dickson VV. Self care in patients with chronic heart failure. Nat Rev
Cardiol. 2011;8(11):644.
14 May CR, Cummings A, Myall M, Harvey J, Pope C, Griffiths P, et al. Experiences of
long-term life-limiting conditions among patients and carers: what can we learn
from a meta-review of systematic reviews of qualitative studies of chronic heart
failure, chronic obstructive pulmonary disease and chronic kidney disease? BMJ
Open. 2016;6:(10) e011694.
15 Eton DT, Yost KJ, Lai JS, Ridgeway JL, Egginton JS, Rosedahl JK, et al. Development
and validation of the Patient Experience with Treatment and Self-management
(PETS): a patient-reported measure of treatment burden. Qual Life Res. 2017;26
(2):489–503.
16 Easton K, Coventry P, Lovell K, Carter L-A, Deaton C. Prevalence and measurement
of anxiety in samples of patients with heart failure: meta-analysis. J Cardiovasc
Nurs. 2016;31(4):367.
17 Celano CM, Villegas AC, Albanese AM, Gaggin HK, Huffman JC. Depression and anxi-
ety in heart failure: a review. Harv Rev Psychiatry. 2018;26(4):175.
18 Kessing D, Denollet J, Widdershoven J, Kupper N. Psychological determinants of
heart failure self-care: systematic review and meta-analysis. Psychosom Med.
2016;78(4):412–431.
374 O.K. Nordfonn et al. / Heart & Lung 50 (2021) 36937419 Sedlar N, Lainscak M, Ma rtensson J, Str€omberg A, Jaarsma T, Farkas J. Factors related
to self-care behaviours in heart failure: a systematic review of European Heart Fail-
ure Self-Care Behaviour Scale studies. Eur J Cardiovasc Nurs. 2017;16(4):272–282.
20 Koirala B, Himmelfarb CD, Budhathoki C, Tankumpuan T, Asano R, Davidson PM.
Factors affecting heart failure self-care: an integrative review. Heart Lung. 2018;47
(6):539–545.
21 Rogers EA, Yost KJ, Rosedahl JK, Linzer M, Boehm DH, Thakur A, et al. Validating the
patient experience with treatment and self-management (PETS), a patient-
reported measure of treatment burden, in people with diabetes. Patient Relat Out-
come Meas. 2017;8:143.
22 Uchmanowicz I, Gobbens RJ. The relationship between frailty, anxiety and depres-
sion, and health-related quality of life in elderly patients with heart failure. Clin
Interv Aging. 2015;10:1595.
23 World Medical Association. WMA declaration of HelsinkiEthical principles for
medical research involving human subjects. 2018. Retrieved from https://www.
wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medi
cal-research-involving-human-subjects/.
24 Husebø AML, Morken IM, Eriksen KS, Nordfonn OK. The patient experience with
treatment and self-management (PETS) questionnaire: translation and cultural
adaption of the Norwegian version. BMC Med Res Methodol. 2018;18(1):147.
25 Cortina JM. What is coefficient alpha? An examination of theory and applications. J
Appl Psychol. 1993;78(1):98.
26 Strand BH, Dalgard OS, Tambs K, Rognerud M. Measuring the mental health status
of the Norwegian population: a comparison of the instruments SCL-25, SCL-10,
SCL-5 and MHI-5 (SF-36). Nordic J Psychiatry. 2003;57(2):113–118.
27 Sandanger I, Moum T, Ingebrigtsen G, Sørensen T, Dalgard O, Bruusgaard D. The
meaning and significance of caseness: the Hopkins Symptom Checklist-25 and the
Composite International Diagnostic Interview II. Soc Psychiatry Psychiatr Epidemiol.
1999;34(1):53–59.
28 Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with
Heart Failure questionnaire: reliability and validity during a randomised, double-
blind, placebo-controlled trial of pimobendan. Am Heart J. 1992;124(4):1017–1025.
29 Buck HG, Dickson VV, Fida R, Riegel B, D’Agostino F, Alvaro R, et al. Predictors of
hospitalisation and quality of life in heart failure: a model of comorbidity, self-effi-
cacy and self-care. Int J Nurs Stud. 2015;52(11):1714–1722.
30 Kraai I, Vermeulen KM, Hillege HL, Jaarsma T. Perception of impairments by
patients with heart failure. Eur J Cardiovasc Nurs. 2016;15(2):178–185.
31 Premchand RK, Sharma K, Mittal S, Monteiro R, Dixit S, Libbus I, et al. Extended fol-
low-up of patients with heart failure receiving autonomic regulation therapy in the
ANTHEM-HF study. J Cardiac Fail. 2016;22(8):639–642.
32 Green SB. How many subjects does it take to do a regression analysis. Multivar
Behav Res. 1991;26(3):499–510.
33 Cohen J. Set correlation and contingency tables. Appl Psychol Meas. 1988;12
(4):425–434.
34 Lee KS, Moser DK, Dracup K. Relationship between self-care and comprehensive
understanding of heart failure and its signs and symptoms. Eur J Cardiovasc Nurs.
2018;17(6):496–504.35 Kristiansen AM, Svanholm JR, Schjødt I, Jensen KM, Silen C, Karlgren K. Patients
with heart failure as co-designers of an educational website: implications for medi-
cal education. Int J Med Educ. 2017;8:47.
36 Senot C. Continuity of care and risk of readmission: An investigation into the
healthcare journey of heart failure patients. Prod Oper Manag. 2019;28(8):2008–
2030.
37 Jones CD, Vu MB, O'Donnell CM, Anderson ME, Patel S, Wald HL, et al. A failure to
communicate: a qualitative exploration of care coordination between hospitalists
and primary care providers around patient hospitalisations. J Gen Intern Med.
2015;30(4):417–424.
38 Uijen AA, Bosch M, van den Bosch WJHM, Bor H, Wensing M, Schers HJ. Heart fail-
ure patients’ experiences with continuity of care and its relation to medication
adherence: a cross-sectional study. BMC Fam Pract. 2012;13(1):86.
39 Vassilev I, Rogers A, Kennedy A, Koetsenruijter J. The influence of social networks
on self-management support: a metasynthesis. BMC Public Health. 2014;14(1):719.
40 Luttik ML, Jaarsma T, Str€omberg A. Changing Needs of Heart Failure Patients and
Their Families During the Illness Trajectory: a Challenge for Health Care. London, Eng-
land: Sage Publications Sage UK; 2016.
41 Nordfonn OK, Morken IM, Lunde Husebø AM. A qualitative study of living with the
burden from heart failure treatment: exploring the patient capacity for self-care.
Nurs Open. 2020;7(3):804–813.
42 Str€omberg A, Ma rtensson J, Fridlund B, Levin L-A

, Karlsson J-E, Dahlstr€om U. Nurse-
led heart failure clinics improve survival and self-care behaviour in patients with
heart failure: results from a prospective, randomised trial. Eur Heart J. 2003;24
(11):1014–1023.
43 Thomas R, Huntley A, Mann M, Huws D, Paranjothy S, Elwyn G, et al. Specialist clinics
for reducing emergency admissions in patients with heart failure: a systematic review
andmeta-analysis of randomised controlled trials.Heart. 2013;99(4):233–239.
44 Riegel B, Lee S, Hill J, Daus M, Baah FO, Wald JW, et al. Patterns of adherence to diu-
retics, dietary sodium and fluid intake recommendations in adults with heart fail-
ure. Heart Lung. 2019;48(3):179–185.
45 Jaarsma T, Cameron J, Riegel B, Stromberg A. Factors related to self-care in heart
failure patients according to the middle-range theory of self-care of chronic illness:
a literature update. Curr Heart Fail Rep. 2017;14(2):71–77.
46 Boehmer KR, Gionfriddo MR, Rodriguez-Gutierrez R, Dabrh AMA, Leppin AL, Har-
graves I, et al. Patient capacity and constraints in the experience of chronic disease: a
qualitative systematic review and thematic synthesis. BMC Fam Pract. 2016;17(1):127.
47 Dobler CC, Harb N, Maguire CA, Armour CL, Coleman C, Murad MH. Treatment bur-
den should be included in clinical practice guidelines. BMJ. 2018;363:k4065.
48 Liu L. Heart Failure: Epidemiology and Research Methods. Elsevier Health Sciences;
2017.
49 Polit DF, Beck CT. International gender bias in nursing research, 20052006: a
quantitative content analysis. Int J Nurs Stud. 2009;46(8):1102–1110.
50 Eton DT, Lee MK, Sauver JL, Anderson RT. Known-groups validity and responsive-
ness to change of the Patient Experience with Treatment and Self-management
(PETS vs. 2.0): a patient-reported measure of treatment burden. Qual Life Res.
2020;29(11):3143–3154.
